BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 6935447)

  • 1. [Diagnosis of acute lymphocytic leukemia using anti-glycolipid antibody].
    Nakahara K
    Rinsho Ketsueki; 1980 Sep; 21(9):1336-9. PubMed ID: 6935447
    [No Abstract]   [Full Text] [Related]  

  • 2. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
    Zipf TF; Fox RI; Dilley J; Levy R
    Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies to soluble blast cell antigens in acute leukemia].
    Golodnenkova VN; Bulycheva TI; Danilevich SV
    Vopr Onkol; 1980; 26(9):17-22. PubMed ID: 6932783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic and enzymatic markers of acute infantile lymphoblastic leukemias].
    González M; Tamagnini G; San Miguel JF; Lopes DT; Mateos G; Caballero MD; Ribeiro L; López Borrasca A
    An Esp Pediatr; 1984 Sep; 21(3):222-8. PubMed ID: 6594963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Surface marker analysis with monoclonal antibodies in childhood acute lymphocytic leukemia].
    Kawai S; Fujimoto T; Yatabe M; Utsumi J; Mimaya J; Sekine I; Okada T; Smike S; Koizumi S; Imashuku S
    Rinsho Ketsueki; 1984 Aug; 25(8):1209-17. PubMed ID: 6334758
    [No Abstract]   [Full Text] [Related]  

  • 6. [The clinical picture and course of acute leukemia in children and its relation to immunologic characteristics of leukemic cells].
    Cáp J; Babusíková O
    Vnitr Lek; 1987 Oct; 33(10):849-58. PubMed ID: 3479858
    [No Abstract]   [Full Text] [Related]  

  • 7. Asialo GM1 as a cell-surface marker detected in acute lymphoblastic leukemia.
    Nakahara K; Ohashi T; Oda T; Hirano T; Kasai M; Okumura K; Tada T
    N Engl J Med; 1980 Mar; 302(12):674-7. PubMed ID: 6153454
    [No Abstract]   [Full Text] [Related]  

  • 8. [Analysis of membrane-associated antigen of human lymphatic neoplasms and its cellular origin using various monoclonal antibodies].
    Tobinai K; Hirose M; Yamada H; Minato K; Shimoyama M
    Nihon Ketsueki Gakkai Zasshi; 1982 Nov; 45(6):1055-68. PubMed ID: 7158260
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute lymphoblastic leukemia: classification and characterization with antisera to human T-cell and Ia antigens.
    Anderson JK; Moore JO; Falletta JM; Terry WF; Metzgar RS
    J Natl Cancer Inst; 1979 Feb; 62(2):293-8. PubMed ID: 310908
    [No Abstract]   [Full Text] [Related]  

  • 10. [Subtypification of acute lymphocytic leukaemia (ALL) in childhood by characterization of immunological surface membrane markers (author's transl)].
    Thränhardt H; Milleck J; Zintl F; Schöntube M; Jantscheff P; Plenert W
    Arch Geschwulstforsch; 1980; 50(3):243-52. PubMed ID: 7002091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of monoclonal antibodies as diagnostic and therapeutic reagents in acute lymphoblastic leukemia.
    Ritz J; Pesando JM; Notis-McConarty J; Clavell LA; Sallan SE; Schlossman SF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4771-5. PubMed ID: 6945904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies on heterogenous expression of cell surface antigens in childhood acute leukemia].
    Kawai S; Yamamoto Y; Utsumi J; Koizumi S; Yanai M; Kawakami K; Iwai T; Ariyoshi N; Oka T; Mimaya J
    Rinsho Ketsueki; 1988 Dec; 29(12):2264-71. PubMed ID: 3246710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunologic characterization of hairy-cell leukemia or tricholeukemia].
    San Miguel JF; González M; Caballero MD; Ríos A; Santoro T; Zola H; López Borrasca A
    Sangre (Barc); 1984; 29(3):280-6. PubMed ID: 6333084
    [No Abstract]   [Full Text] [Related]  

  • 14. [Acute lymphocytic leukemia--immunological classification and prognosis].
    Chen P; Ho C; Hwang T; Ogasawara M; Kikuchi K
    Rinsho Ketsueki; 1982 Oct; 23(10):1555-60. PubMed ID: 6961243
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cell surface markers of childhood leukemias and lymphomas].
    Shibuya A; Shinozawa T; Yoshikawa T; Katayama I
    Rinsho Ketsueki; 1985 Jan; 26(1):7-14. PubMed ID: 3158761
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
    Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
    Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune function at diagnosis in relation to responses to therapy in acute lymphocytic leukemia of childhood.
    Jose DG; Ekert H; Colebatch J; Waters K; Wilson F; O'Keefe D
    Blood; 1976 Jun; 47(6):1011-21. PubMed ID: 1084177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Heterogeneity of surface characteristics of lymphoid cells altered by malignancy].
    Batinić D; Boranić M
    Lijec Vjesn; 1985 Jul; 107(7):273-7. PubMed ID: 3160902
    [No Abstract]   [Full Text] [Related]  

  • 19. Southwest Oncology Group experience with immunological phenotyping in acute lymphocytic leukemia of childhood.
    Pullen DJ; Falletta JM; Crist WM; Vogler LB; Dowell B; Humphrey GB; Blackstock R; Eys JV; Cooper MD; Metzgar RS; Meydrech EF
    Cancer Res; 1981 Nov; 41(11 Pt 2):4802-9. PubMed ID: 6975163
    [No Abstract]   [Full Text] [Related]  

  • 20. [Identification of lymphatic neoplasms by antibody assay].
    Kikuchi K
    Hokkaido Igaku Zasshi; 1982 May; 57(3):281-6. PubMed ID: 6982214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.